Richard V. McCloskey
- Epidemiology top 5%
- Immunology top 5%
- Rheumatology top 2%
- Molecular Biology
- Oncology
- Co-authors
- Ravinder N. MainiEwa PaleologSylvia YoungMarc FeldmannPeter C. TaylorMichael J. ElliottA. Michael PetersPeter T. Chapman
- Topics
- Antibiotics Pharmacokinetics and Efficacy (6 papers)Antimicrobial Resistance in Staphylococcus (5 papers)interferon and immune responses (4 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Richard V. McCloskey
31 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 109
- Epidemiology 488
- Immunology 473
- Rheumatology 378
- Molecular Biology 260
- Oncology 191
Countries citing papers authored by Richard V. McCloskey
This map shows the geographic impact of Richard V. McCloskey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard V. McCloskey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard V. McCloskey more than expected).
Fields of papers citing papers by Richard V. McCloskey
This network shows the impact of papers produced by Richard V. McCloskey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard V. McCloskey. The network helps show where Richard V. McCloskey may publish in the future.
Co-authorship network of co-authors of Richard V. McCloskey
This figure shows the co-authorship network connecting the top 25 collaborators of Richard V. McCloskey. A scholar is included among the top collaborators of Richard V. McCloskey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard V. McCloskey. Richard V. McCloskey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 330 | |
| 2 | 44 | |
| 3 | 58 | |
| 4 | 106 | |
| 5 | 269 | |
| 6 | 23 | |
| 7 | 337 | |
| 8 | 40 | |
| 9 | 20 | |
| 10 | Periodic fever. Diagnostic and therapeutic problems. | 12 |
| 11 | 11 | |
| 12 | 28 | |
| 13 | 12 | |
| 14 | 41 | |
| 15 | 1 | |
| 16 | 27 | |
| 17 | 28 | |
| 18 | 23 | |
| 19 | 4 | |
| 20 | 6 |
About Richard V. McCloskey
Richard V. McCloskey is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Endocrinology, having authored 31 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and interferon and immune responses (4 papers). The work is most often cited by research in Rheumatology (378 citations), Immunology (473 citations) and Critical Care and Intensive Care Medicine (110 citations). Richard V. McCloskey has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Ravinder N. Maini, Ewa Paleolog, Sylvia Young, Marc Feldmann, Peter C. Taylor, Michael J. Elliott, A. Michael Peters, Marc Feldmann, Peter T. Chapman and Charles E. Buckler. Their work appears in journals such as Annals of Internal Medicine, The Journal of Immunology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.